Original Research Focus on Suicide February 21, 2024

Associations of MSK1 Methylation and Executive Function With Suicidal Ideation in Adolescents With Major Depressive Disorder: A Prospective Cohort Study

Peiwei Xu, MD, PhD; Yuanmei Tao, MD; Hang Zhang, MD; Meijiang Jin, MD; Hanmei Xu, MD; Shoukang Zou, MD; Fang Deng, MD; Lijuan Huang, MD; Hong Zhang, MD; Xiaolan Wang, MD; Xiaowei Tang, MD; Yanping Wang, MD; Li Yin, MD, PhD; Xueli Sun, MD

J Clin Psychiatry 2024;85(1):23m14996

ABSTRACT

Objective: Adolescent suicide is a major public health problem, and risk of suicide is higher among those with major depressive disorder (MDD), which may be linked to alterations in mitogen- and stress-activated kinase 1 (MSK1) and to defects in executive function. Here, we aimed to investigate the potential impacts of executive function and MSK1 methylation on suicidal ideation in adolescents with MDD.

Methods: The study enrolled 66 drug-naive adolescents who were experiencing their first episode of MDD from February 2019 until October 2020. After 6 weeks of receiving antidepressant treatment, 65 participants remained in the study. Suicidal ideation and depressive severity were assessed using the Hamilton Depression Rating Scale, while executive function was evaluated using the Cambridge Neuropsychological Test Automated Battery. MSK1 methylation was measured using bisulfite DNA analysis.

Results: Among the 66 adolescents with MDD, 43 (65.15%) reported suicidal ideation, while 23 (34.85%) did not. Individuals with suicidal ideation had worse executive function and higher MSK1 methylation than those without suicidal ideation. The MSK1 methylation percentage may predict suicidal ideation in adolescents with MDD (odds ratio [OR] 1.227, 95% CI [1.031 to 1.461]). Improvement in executive function was significantly associated with reduced suicidal ideation during antidepressant treatment (β = −0.200, 95% CI [−0.877 to −0.085]).

Conclusions: Our results strengthen the evidence for a link among MSK1 methylation, executive function, and suicidal ideation in adolescent MDD.

Trial Registration: Chinese Clinical Trial Registry identifier: ChiCTR2000033402

J Clin Psychiatry 2024;85(1):23m14996

Author affiliations are listed at the end of this article.

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

  1. Cha CB, Franz PJ, M Guzmán E, et al. Annual research review: suicide among youth—epidemiology, (potential) etiology, and treatment. J Child Psychol Psychiatry. 2018;59(4):460–482. PubMed CrossRef
  2. Fonseca-Pedrero E, Díez-Gómez A, de la Barrera U, et al. Suicidal behaviour in adolescents: a network analysis. Rev Psiquiatr Salud Ment (Engl Ed). 2020;S1888-9891(20)30032-X. PubMed
  3. Mortier P, Cuijpers P, Kiekens G, et al. The prevalence of suicidal thoughts and behaviours among college students: a meta-analysis. Psychol Med. 2018;48(4):554–565. PubMed CrossRef
  4. Nock MK, Green JG, Hwang I, et al. Prevalence, correlates, and treatment of lifetime suicidal behavior among adolescents: results from the National Comorbidity Survey Replication Adolescent Supplement. JAMA Psychiatry. 2013;70(3):300–310. PubMed CrossRef
  5. Castellví P, Lucas-Romero E, Miranda-Mendizábal A, et al. Longitudinal association between self-injurious thoughts and behaviors and suicidal behavior in adolescents and young adults: a systematic review with meta-analysis. J Affect Disord. 2017;215:37–48. PubMed CrossRef
  6. Miller AB, Prinstein MJ. Adolescent suicide as a failure of acute stress-response systems. Annu Rev Clin Psychol. 2019;15(1):425–450. PubMed CrossRef
  7. Fonseca-Pedrero E, Díez-Gómez A, de la Barrera U, et al. Conducta suicida en adolescentes: un análisis de redes. Rev Psiquiatr Salud Ment. 2020:rpsm.2020.04.007. CrossRef
  8. Banich MT. Executive function: the search for an integrated account. Curr Dir Psychol Sci. 2009;18(2):89–94. CrossRef
  9. Bortolato B, Carvalho AF, McIntyre RS. Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review. CNS Neurol Disord Drug Targets. 2014;13(10):1804–1818. PubMed CrossRef
  10. Ho M-C, Hsu Y-C, Lu M-L, et al. ‘Cool’ and ‘hot’ executive functions in suicide attempters with major depressive disorder. J Affect Disord. 2018;235:332–340. PubMed CrossRef
  11. Bredemeier K, Miller IW. Executive function and suicidality: a systematic qualitative review. Clin Psychol Rev. 2015;40:170–183. PubMed CrossRef
  12. Sommerfeldt SL, Cullen KR, Han G, et al. Executive attention impairment in adolescents with major depressive disorder. J Clin Child Adolesc Psychol. 2016;45(1):69–83. PubMed CrossRef
  13. Bridge JA, McBee-Strayer SM, Cannon EA, et al. Impaired decision making in adolescent suicide attempters. J Am Acad Child Adolesc Psychiatry. 2012;51(4):394–403. PubMed CrossRef
  14. Ortuño-Sierra J, Aritio-Solana R, Del Casal ADG, et al. Neurocognitive functioning in adolescents at risk for suicidal behaviors. Arch Suicide Res. 2021;25(3):657–671. PubMed CrossRef
  15. Barzilay R, Calkins ME, Moore TM, et al. Neurocognitive functioning in community youth with suicidal ideation: gender and pubertal effects. Br J Psychiatry. 2019;215(3):552–558. PubMed CrossRef
  16. Roca M, Del Amo AR-L, Riera-Serra P, et al. Suicidal risk and executive functions in major depressive disorder: a study protocol. BMC Psychiatry. 2019;19(1):253. PubMed CrossRef
  17. Policicchio S, Washer S, Viana J, et al. Genome-wide DNA methylation meta-analysis in the brains of suicide completers. Transl Psychiatry. 2020;10(1):69. PubMed CrossRef
  18. Labonté B, Suderman M, Maussion G, et al. Genome-wide methylation changes in the brains of suicide completers. Am J Psychiatry. 2013;170(5):511–520. PubMed CrossRef
  19. Kang H-J, Kim J-M, Lee J-Y, et al. BDNF promoter methylation and suicidal behavior in depressive patients. J Affect Disord. 2013;151(2):679–685. PubMed CrossRef
  20. Ropret S, Kouter K, Zupanc T, et al. BDNF methylation and mRNA expression in brain and blood of completed suicides in Slovenia. World J Psychiatry. 2021;11(12):1301–1313. PubMed CrossRef
  21. Wagner S, Kayser S, Engelmann J, et al. Plasma brain-derived neurotrophic factor (pBDNF) and executive dysfunctions in patients with major depressive disorder. World J Biol Psychiatry. 2019;20(7):519–530. PubMed CrossRef
  22. Cooper DD, Frenguelli BG. The influence of sensory experience on the glutamatergic synapse. Neuropharmacology. 2021;193:108620. PubMed CrossRef
  23. Daumas S, Hunter CJ, Mistry RB, et al. The kinase function of MSK1 regulates BDNF signaling to CREB and basal synaptic transmission, but is not required for hippocampal long-term potentiation or spatial memory. eNeuro. 2017;4(1):ENEURO.0212-16.2017. PubMed CrossRef
  24. Reyskens KMSE, Arthur JSC. Emerging roles of the mitogen and stress activated kinases MSK1 and MSK2. Front Cell Dev Biol. 2016;4:56. PubMed CrossRef
  25. Privitera L, Morè L, Cooper DD, et al. Experience recruits MSK1 to expand the dynamic range of synapses and enhance cognition. J Neurosci. 2020;40(24):4644–4660. PubMed CrossRef
  26. Bryan CJ, Rozek DC. Suicide prevention in the military: a mechanistic perspective. Curr Opin Psychol. 2018;22:27–32. PubMed CrossRef
  27. Novak LA, Carter SP, LaCroix JM, et al. Cognitive flexibility and suicide risk indicators among psychiatric inpatients. Psychiatry Res. 2022;313:114594. PubMed CrossRef
  28. Xu P, Tao Y, Zhang H, et al. RPS6KA5 methylation predict response to 6-week treatment for adolescent MDD patients. BMC Psychiatry. 2022;22(1):561. PubMed CrossRef
  29. Hoy KE, Thomson RH, Cherk M, et al. Effect of magnetic seizure therapy on regional brain glucose metabolism in major depression. Psychiatry Res. 2013;211(2):169–175. PubMed CrossRef
  30. Zheng YP, Zhao JP, Phillips M, et al. Validity and reliability of the Chinese Hamilton Depression Rating Scale. Br J Psychiatry. 1988;152(5):660–664. PubMed CrossRef
  31. Hayasaka Y, Purgato M, Magni LR, et al. Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials. J Affect Disord. 2015;180:179–184. PubMed CrossRef
  32. Fray PJ, Robbins TW, Sahakian BJ. Neuropsychiatric applications of CANTAB. Int J Geriatr Psychiatry. 1996;11:329–336. CrossRef
  33. Lalovic A, Wang S, Keilp JG, et al. A qualitative systematic review of neurocognition in suicide ideators and attempters: implications for cognitive-based psychotherapeutic interventions. Neurosci Biobehav Rev. 2022;132:92–109. PubMed CrossRef
  34. Gifuni AJ, Perret LC, Lacourse E, et al. Decision-making and cognitive control in adolescent suicidal behaviors: a qualitative systematic review of the literature. Eur Child Adolesc Psychiatry. 2021;30(12):1839–1855. PubMed CrossRef
  35. Stewart JG, Glenn CR, Esposito EC, et al. Cognitive control deficits differentiate adolescent suicide ideators from attempters. J Clin Psychiatry. 2017;78(6):e614–e621. PubMed CrossRef
  36. Zhou Y, Wang C, Lan X, et al. Cognitive function mediates the anti-suicide effect of repeated intravenous ketamine in adult patients with suicidal ideation. Front Psychiatry. 2022;13:779326. PubMed CrossRef
  37. Zhou Y, Wang C, Lan X, et al. The potential pro-cognitive effects with intravenous subanesthetic ketamine in adults with treatment-resistant major depressive or bipolar disorders and suicidality. J Psychiatr Res. 2021;144:312–319. PubMed CrossRef
  38. Fernández-Sevillano J, Alberich S, Zorrilla I, et al. Cognition in recent suicide attempts: altered executive function. Front Psychiatry. 2021;12:701140. PubMed CrossRef
  39. Rutter SB, Cipriani N, Smith EC, et al. Neurocognition and the suicidal process. Curr Top Behav Neurosci. 2020;46:117–153. PubMed CrossRef
  40. Keller S, Sarchiapone M, Zarrilli F, et al. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry. 2010;67(3):258–267. PubMed CrossRef
  41. Corrêa SAL, Hunter CJ, Palygin O, et al. MSK1 regulates homeostatic and experience-dependent synaptic plasticity. J Neurosci. 2012;32(38):13039–13051. PubMed CrossRef
  42. Ji C-H, Gu J-H, Liu Y, et al. Hippocampal MSK1 regulates the behavioral and biological responses of mice to chronic social defeat stress: Involving of the BDNF-CREB signaling and neurogenesis. Biochem Pharmacol. 2022;195:114836. PubMed CrossRef
  43. Webb LM, Phillips KE, Ho MC, et al. The relationship between DNA methylation and antidepressant medications: a systematic review. Int J Mol Sci. 2020;21(3):826. PubMed CrossRef
  44. Law P-P, Holland ML. DNA methylation at the crossroads of gene and environment interactions. Essays Biochem. 2019;63(6):717–726. PubMed CrossRef